Education
About Us
Working with TipRanks
Follow Us
Beauty Farm Medical & Health Industry, Inc. (HK:2373)
:2373
2373 Stock Chart & Stats
HK$26.36
HK$0.14(0.75%)
At close: 4:00 PM EST
HK$26.36
HK$0.14(0.75%)
Day’s Range― - ―
52-Week RangeHK$15.20 - HK$41.60
Previous CloseN/A
Volume52.00K
Average Volume (3M)539.77K
Market Cap
HK$6.67B
Enterprise ValueHK$6.24B
Total Cash (Recent Filing)HK$2.00B
Total Debt (Recent Filing)HK$779.08M
Price to Earnings (P/E)21.3
Beta0.31
Next Earnings
Apr 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.97%
Share Statistics
EPS (TTM)0.76
Shares Outstanding251,593,720
10 Day Avg. Volume911,428
30 Day Avg. Volume539,766
Financial Highlights & Ratios
PEG Ratio3.17
Price to Book (P/B)4.08
Price to Sales (P/S)1.50
P/FCF Ratio5.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$38.69Price Target Upside46.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained ~20% revenue growth across core aesthetic services and product sales indicates durable market demand and successful commercial execution. Over the medium term this supports scale benefits, incremental margin expansion opportunities, and provides a larger base for reinvestment into services, products and network expansion.
Free Cash Flow StrengthMaterial FCF growth reflects strong cash conversion and operational efficiency, supplying internal funding for capex, working capital and strategic initiatives without heavy external financing. This bolsters financial resilience, supports shareholder returns, and enhances the firm's ability to pursue sustained expansion or M&A over months.
High Return On EquityA 24.2% ROE signals efficient capital allocation and profitable core operations, suggesting management extracts high returns from invested capital. Persistently high ROE underpins long-term shareholder value creation, aids retention of investor confidence, and indicates competitive positioning in the medical aesthetic market.
Bears Say
Moderate Leverage / Low Equity RatioModerate leverage combined with a relatively low equity ratio reduces the capital cushion against shocks and can constrain financial flexibility. In adverse conditions or when pursuing aggressive expansion, the firm may face higher refinancing costs or limited room for additional debt, affecting strategic optionality.
Declining EBITDA MarginA falling EBITDA margin signals rising cost pressures or declining operational efficiency that could erode operating leverage. If persistent, this trend can compress cash available for reinvestment and debt servicing, making it harder to sustain growth and fund strategic initiatives without restoring margin performance.
Limited Investor CommunicationThe absence of earnings call disclosures and notable corporate event communications reduces transparency around strategy, guidance and management priorities. Over time this can weaken investor confidence, hinder external scrutiny of execution, and complicate market assessment of long-term strategic shifts or risks.
Beauty Farm Medical & Health Industry, Inc. News
2373 FAQ
What was Beauty Farm Medical & Health Industry, Inc.’s price range in the past 12 months?
Beauty Farm Medical & Health Industry, Inc. lowest stock price was HK$15.20 and its highest was HK$41.60 in the past 12 months.
What is Beauty Farm Medical & Health Industry, Inc.’s market cap?
Beauty Farm Medical & Health Industry, Inc.’s market cap is HK$6.67B.
When is Beauty Farm Medical & Health Industry, Inc.’s upcoming earnings report date?
Beauty Farm Medical & Health Industry, Inc.’s upcoming earnings report date is Apr 01, 2026 which is in 59 days.
How were Beauty Farm Medical & Health Industry, Inc.’s earnings last quarter?
Beauty Farm Medical & Health Industry, Inc. released its earnings results on Aug 26, 2025. The company reported HK$0.764 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.764.
Is Beauty Farm Medical & Health Industry, Inc. overvalued?
According to Wall Street analysts Beauty Farm Medical & Health Industry, Inc.’s price is currently Undervalued.
Does Beauty Farm Medical & Health Industry, Inc. pay dividends?
Beauty Farm Medical & Health Industry, Inc. pays a Annually dividend of HK$0.52 which represents an annual dividend yield of 1.97%. See more information on Beauty Farm Medical & Health Industry, Inc. dividends here
What is Beauty Farm Medical & Health Industry, Inc.’s EPS estimate?
Beauty Farm Medical & Health Industry, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beauty Farm Medical & Health Industry, Inc. have?
Beauty Farm Medical & Health Industry, Inc. has 251,593,720 shares outstanding.
What happened to Beauty Farm Medical & Health Industry, Inc.’s price movement after its last earnings report?
Beauty Farm Medical & Health Industry, Inc. reported an EPS of HK$0.764 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.258%.
Which hedge fund is a major shareholder of Beauty Farm Medical & Health Industry, Inc.?
Currently, no hedge funds are holding shares in HK:2373
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beauty Farm Medical & Health Industry, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
HK$38.69 (46.79% Upside)
HK$38.69 (46.79% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
96.26%
12-Months-Change
Fundamentals
Return on Equity
31.23%
Trailing 12-Months
Asset Growth
28.93%
Trailing 12-Months
Company Description
Beauty Farm Medical & Health Industry, Inc.
Beauty Farm Medical and Health Industry Inc. provides beauty and health management services in the People's Republic of China It offers traditional beauty services; aesthetic medical services, including non-surgical aesthetic medical services, such as energy-based services and injection services, as well as surgical aesthetic medical services; and subhealth assessment and intervention services. As of June 30, 2022, the company operated 352 stores, including 177 direct stores and 175 franchised stores under the BeautyFarm, Palaispa, Neology, and CellCare brand names. The company was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.
2373 Stock 12 Month Forecast
Average Price Target
HK$38.69
▲(46.79% Upside)
Technical Analysis
Rici Healthcare Holdings Ltd.
―
Jinxin Fertility Group Ltd.
―
Raily Aesthetic Medicine International Holdings Limited
―
Gushengtang Holdings Limited
―
Hygeia Healthcare Holdings Co., Ltd.
―
Options Prices
Currently, No data available
---